148 related articles for article (PubMed ID: 15290006)
21. [Animal models of schizophrenia using different laboratory mouse strains].
Wu JH; Zou H; Yu J; Zhou XD; Xie QL; Jin ML
Sheng Li Xue Bao; 2003 Aug; 55(4):381-7. PubMed ID: 12937815
[TBL] [Abstract][Full Text] [Related]
22. Sensitivity to MK-801 in phospholipase C-β1 knockout mice reveals a specific NMDA receptor deficit.
Gray L; McOmish CE; Scarr E; Dean B; Hannan AJ
Int J Neuropsychopharmacol; 2009 Aug; 12(7):917-28. PubMed ID: 19236734
[TBL] [Abstract][Full Text] [Related]
23. Functional Interaction Between NMDA and mGlu5 Receptors: Effects on Working Memory, Instrumental Learning, Motor Behaviors, and Dopamine Release.
Homayoun H; Stefani MR; Adams BW; Tamagan GD; Moghaddam B
Neuropsychopharmacology; 2004 Jul; 29(7):1259-69. PubMed ID: 15010696
[TBL] [Abstract][Full Text] [Related]
24. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML
J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968
[TBL] [Abstract][Full Text] [Related]
25. Behavioral sensitization to ethanol does not result in cross-sensitization to NMDA receptor antagonists.
Meyer PJ; Phillips TJ
Psychopharmacology (Berl); 2007 Nov; 195(1):103-15. PubMed ID: 17653696
[TBL] [Abstract][Full Text] [Related]
26. Repetitive behavior profile and supersensitivity to amphetamine in the C58/J mouse model of autism.
Moy SS; Riddick NV; Nikolova VD; Teng BL; Agster KL; Nonneman RJ; Young NB; Baker LK; Nadler JJ; Bodfish JW
Behav Brain Res; 2014 Feb; 259():200-14. PubMed ID: 24211371
[TBL] [Abstract][Full Text] [Related]
27. MK-801 and cognitive functions: Investigating the behavioral effects of a non-competitive NMDA receptor antagonist.
Janus A; Lustyk K; Pytka K
Psychopharmacology (Berl); 2023 Dec; 240(12):2435-2457. PubMed ID: 37725119
[TBL] [Abstract][Full Text] [Related]
28. Neonatal exposure to MK-801, an N-methyl-D-aspartate receptor antagonist, enhances methamphetamine-induced locomotion and disrupts sensorimotor gating in pre- and postpubertal rats.
Uehara T; Sumiyoshi T; Seo T; Matsuoka T; Itoh H; Suzuki M; Kurachi M
Brain Res; 2010 Sep; 1352():223-30. PubMed ID: 20633540
[TBL] [Abstract][Full Text] [Related]
29. Mice lacking D-amino acid oxidase activity display marked attenuation of stereotypy and ataxia induced by MK-801.
Hashimoto A; Yoshikawa M; Niwa A; Konno R
Brain Res; 2005 Feb; 1033(2):210-5. PubMed ID: 15694926
[TBL] [Abstract][Full Text] [Related]
30. MK-801 prevents the development of behavioral sensitization during repeated morphine administration.
Jeziorski M; White FJ; Wolf ME
Synapse; 1994 Feb; 16(2):137-47. PubMed ID: 8197575
[TBL] [Abstract][Full Text] [Related]
31. Does dizocilpine (MK-801) selectively block the enhanced responsiveness to repeated amphetamine administration?
Segal DS; Kuczenski R; Florin SM
Behav Neurosci; 1995 Jun; 109(3):532-46. PubMed ID: 7662163
[TBL] [Abstract][Full Text] [Related]
32. Effect of riluzole on MK-801 and amphetamine-induced hyperlocomotion.
Lourenço Da Silva A; Hoffmann A; Dietrich MO; Dall'Igna OP; Souza DO; Lara DR
Neuropsychobiology; 2003; 48(1):27-30. PubMed ID: 12886037
[TBL] [Abstract][Full Text] [Related]
33. Locomotor activity induced by MK-801 is enhanced in dopamine D3 receptor knockout mice but suppression by dopamine D3/D2 antagonists does not occur through the dopamine D3 receptor.
Yarkov AV; Der TC; Joyce JN
Eur J Pharmacol; 2010 Feb; 627(1-3):167-72. PubMed ID: 19900441
[TBL] [Abstract][Full Text] [Related]
34. Pyrroloquinoline quinone prevents MK-801-induced stereotypical behavior and cognitive deficits in mice.
Zhou X; Chen Q; Hu X; Mao S; Kong Y
Behav Brain Res; 2014 Jan; 258():153-9. PubMed ID: 24149067
[TBL] [Abstract][Full Text] [Related]
35. Phencyclidine and dizocilpine induced behaviors reduced by N-acetylaspartylglutamate peptidase inhibition via metabotropic glutamate receptors.
Olszewski RT; Wegorzewska MM; Monteiro AC; Krolikowski KA; Zhou J; Kozikowski AP; Long K; Mastropaolo J; Deutsch SI; Neale JH
Biol Psychiatry; 2008 Jan; 63(1):86-91. PubMed ID: 17597589
[TBL] [Abstract][Full Text] [Related]
36. N-methyl-D-aspartate receptor antagonist and dopamine D1 and D2 agonist interactions in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced hemiparkinsonian monkeys.
Domino EF; Sheng J
J Pharmacol Exp Ther; 1993 Jan; 264(1):221-5. PubMed ID: 8093726
[TBL] [Abstract][Full Text] [Related]
37. Expression of NR1, NR2A and NR2B NMDA receptor subunits is not altered in the genetically-inbred Balb/c mouse strain with heightened behavioral sensitivity to MK-801, a noncompetitive NMDA receptor antagonist.
Perera PY; Lichy JH; Mastropaolo J; Rosse RB; Deutsch SI
Eur Neuropsychopharmacol; 2008 Nov; 18(11):814-9. PubMed ID: 18674888
[TBL] [Abstract][Full Text] [Related]
38. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
Gaisler-Salomon I; Weiner I
Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
[TBL] [Abstract][Full Text] [Related]
39. Minocycline attenuates hyperlocomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpine.
Zhang L; Shirayama Y; Iyo M; Hashimoto K
Neuropsychopharmacology; 2007 Sep; 32(9):2004-10. PubMed ID: 17228338
[TBL] [Abstract][Full Text] [Related]
40. Characterization of MK-801-induced behavior as a putative rat model of psychosis.
Andiné P; Widermark N; Axelsson R; Nyberg G; Olofsson U; Mårtensson E; Sandberg M
J Pharmacol Exp Ther; 1999 Sep; 290(3):1393-408. PubMed ID: 10454519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
